Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
McKinsey
QuintilesIMS
Deloitte
Medtronic
Argus Health
Boehringer Ingelheim
Cipla
Covington

Generated: February 22, 2019

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR PIOGLITAZONE HYDROCHLORIDE AND GLIMEPIRIDE

« Back to Dashboard

Clinical Trials for Pioglitazone Hydrochloride And Glimepiride

Trial ID Title Status Sponsor Phase Summary
NCT00225264 Efficacy Study of Pioglitazone and Glimepiride on the Rate of Progression of Atherosclerotic Disease. Completed Takeda Phase 3 The primary purpose of this study is to compare the effects of pioglitazone, once daily (QD), versus glimepiride on the amount of thickening of the carotid artery.
NCT00225277 Efficacy Study of Pioglitazone Compared to Glimepiride on Coronary Atherosclerotic Disease Progression in Subjects With Type 2 Diabetes Mellitus Completed Takeda Phase 3 The purpose of this study was to determine the efficacy of pioglitazone, once daily (QD), compared to glimepiride on atherosclerotic disease measured by intravascular ultrasound.
NCT00576784 Metabolic Effects of Pioglitazone in Type II Diabetic Patients Previously Treated With Insulin Completed IKFE Institute for Clinical Research and Development Phase 4 The goal of the study is to demonstrate whether a switch from insulin therapy to an oral therapy with pioglitazone/glimepiride will lead to a deterioration of glycemic control (increase in HbA1c by more than 0.5 %) within a 6 month observation period.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Pioglitazone Hydrochloride And Glimepiride

Condition Name

Condition Name for Pioglitazone Hydrochloride And Glimepiride
Intervention Trials
Diabetes Mellitus, Type 2 5
Type 2 Diabetes Mellitus 5
Diabetes Mellitus 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Pioglitazone Hydrochloride And Glimepiride
Intervention Trials
Diabetes Mellitus 16
Diabetes Mellitus, Type 2 15
Insulin Resistance 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Pioglitazone Hydrochloride And Glimepiride

Trials by Country

Trials by Country for Pioglitazone Hydrochloride And Glimepiride
Location Trials
United States 127
Germany 32
Canada 12
Italy 10
United Kingdom 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Pioglitazone Hydrochloride And Glimepiride
Location Trials
Florida 4
Oklahoma 4
California 4
Louisiana 4
Minnesota 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Pioglitazone Hydrochloride And Glimepiride

Clinical Trial Phase

Clinical Trial Phase for Pioglitazone Hydrochloride And Glimepiride
Clinical Trial Phase Trials
Phase 4 8
Phase 3 7
N/A 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Pioglitazone Hydrochloride And Glimepiride
Clinical Trial Phase Trials
Completed 12
Recruiting 3
Active, not recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Pioglitazone Hydrochloride And Glimepiride

Sponsor Name

Sponsor Name for Pioglitazone Hydrochloride And Glimepiride
Sponsor Trials
Takeda 7
IKFE Institute for Clinical Research and Development 2
Second University of Naples 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Pioglitazone Hydrochloride And Glimepiride
Sponsor Trials
Industry 13
Other 12
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Johnson and Johnson
QuintilesIMS
Moodys
Argus Health
Mallinckrodt
Baxter
Fish and Richardson
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.